CONTENTS:
- Reducing the risks of distortion in cannabis research [Editorial]. Humphreys K., Hall W.D., p. 799-801.
- Should cigarette pack sizes be capped? [Addiction Opinion and Debate]. Blackwell A.K.M., Lee I., Scollo M., Wakefield M., Munafo M.R., Marteau T.M., p. 802-809.
- We do not yet understand the psychological mechanisms explaining how cigarette pack size affects smoking, let alone smoking cessation. Willemsen M., Steenhuis I., p. 810-811.
- Are there lessons from gambling control for tobacco control? Farrell L., p. 811-812.
- The importance of loose tobacco when considering capping pack size. Moodie C., Stead M., p. 812-814.
- What's in a number? Cummings K.M., p. 814-815.
- Size matters but when, why and for whom? Blackwell A.K.M., Lee I., Scollo M., Wakefield M., Munafo M.R., Marteau T.M., p. 815-816.
- Experimental manipulations of behavioral economic demand for addictive commodities: a meta-analysis. Acuff S.F., Amlung M., Dennhardt A.A., MacKillop J., Murphy J.G., p. 817-831.
- Prevalence of respiratory conditions among people who use illicit opioids: a systematic review. Hulin J., Brodie A., Stevens J., Mitchell C., p. 832-849.
- Problem drinking, wellbeing and mortality risk in Chinese men: findings from the China Kadoorie Biobank. Im P.K., Millwood I.Y., Chen Y., Guo Y., Du H., Kartsonaki C., et al., p. 850-862.
- High- versus low-intensity internet interventions for alcohol use disorders: results of a three-armed randomized controlled superiority trial. Sundström C., Eék N., Kraepelien M., Fahlke C., Gajecki M., Jakobson M., et al., p. 863-874.
- Commentary on Sundström et al. (2019): Digital interventions for alcohol problems - time for more research on blended therapy. Blankers M., p. 875-876.
- Which adolescent factors predict alcohol misuse in young adulthood? A co-twin comparisons study. Stephenson M., Barr P., Ksinan A., Aliev F., Latvala A., Viken R., et al., p. 877-887.
- Frequent intoxication and alcohol tolerance in adolescence: associations with psychiatric disorders in young adulthood. Sarala M., Miettunen J., Koskela J., Mustonen A., Rose R.J., Hurtig T., et al., p. 888-900.
- Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study. Bretana N.A., Gray R.R., Cunningham E.B., Betz-Stablein B., Ribeiro R., Graw F., et al., p. 901-913.
- Prisons can also improve drug user health in the community. Martin N.K., Hickman M., Spaulding A.C., Vickerman P., p. 914-915.
- Commentary on Bretana et al. (2020): Prevention and treatment in the prison setting will be key to achieving HCV elimination. Aspinall E.J., Fernandez-Montero J.V., p. 915-916.
- Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial. Blanken P., Nuijten M., van den Brink W., Hendriks V.M., p. 917-923.
- Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Park T.W., Larochelle M.R., Saitz R., Wang N., Bernson D., Walley A.Y., p. 924-932.
- Commentary on Park et al. (2020): Buprenorphine and benzodiazepine co-prescribing- key considerations and future directions. Oliva E.M., p. 933-934.
- Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions. Pacek L.R., Weinberger A.H., Zhu J., Goodwin R.D., p. 935-943.
- Commentary on Pacek et al. (2019): Cannabis and major depression-a network theory proposal. Boden J.M., Monk N.J., p. 944-945.
- The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States. Hoots B., Vivolo-Kantor A., Seth P., p. 946-958.
- Commentary on Hoots et al. (2019): The gap between evidence and policy calls into question the extent of a public health approach to the opioid overdose epidemic. Nolan M.L., Allen B., Paone D., p. 959-960.
- Association of prevalence of electronic cigarette use with smoking cessation and cigarette consumption in England: a time-series analysis between 2006 and 2017. Beard E., West R., Michie S., Brown J., p. 961-974.
- Commentary on Beard et al. (2019): A systematic approach sharpens insights on e-cigarettes and smoking cessation. Villanti A.C., Pearson J.L., p. 975-976.
- Comparison of Allen Carr's Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial. Frings D., Albery I.P., Moss A.C., Brunger H., Burghelea M., White S., et al., p. 977-985.
- Diffusion of effects of the ASSIST school-based smoking prevention intervention to non-participating family members: a secondary analysis of a randomized controlled trial. White J., Holliday J., Daniel R., Campbell R., Moore L., p. 986-991.
- Commentary on White et al. (2019): Future directions in studying the diffusion of intervention effects. Rulison K.L., p. 992-993.